| Receipt no. | First name | Last name | Abstract title |
|---|
| 10039 | Shunsuke | Kubo | Incidence, Characteristics, and Clinical Course of Device-Related Thrombus after Watchman Device Implantation in Atrial Fibrillation Patients |
| 10052 | Akino | Yoshimura | Evaluation of Safety and Efficacy of Periprocedural use of Rivaroxaban and Apixaban in Atrial Fibrillation Ablation |
| 10072 | Yoko | Ito | Predictors of left atrial stunning just after electrical cardioversion in the patients with atrial fibrillation |
| 10143 | Yukiko | Mizutani | Efficacy and safety of the left appendage closure with the WATCHMAN device; single center experience |
| 10211 | Yusuke | Namba | Clinical Significance of Platelet Reactivity during Prasugrel Therapy in Patients with Acute Myocardial Infarction |
| 10268 | Shinya | Suzuki | Difference of 2-year Morbidity between Direct Oral Anticoagulants and Warfarin in Anticoagulated Patients with Non-valvular Atrial Fibrillation |
| 10359 | Kozue | Ikeda | Anti-factor Xa Assay Assisted Management of Directect Xa-inhibitors in Patients with Non-valvular Atrial Fibrillation |
| 10374 | Satoshi | Nishimura | Two Photon Real-time Imaging of Microcirculation in Living Mice Revealed Tight Association among Endothelium Injury, Hypoxia, Inflammation, and Thrombus Formation |
| 10461 | Taiju | Matsui | Serum soluble thrombomodulin level on admission is a useful predictor for treatment response in patients with acute pulmonary thromboembolism |
| 10660 | Shinya | Ichikawa | Platelet reactivity in patients with ST-elevation or non-ST elevation acute coronary syndromes receiving prasugrel |
| 10738 | Hiroyuki | Sakai | A Study of Safety and Efficacy of Anticoagulant Therapy in the Treatment of Atrial Fibrillation in Kanagawa (ASSAF-K) |
| 10778 | Yohsuke | Honda | New scoring model to predict bleeding events within 2 year after DES implantation |
| 10807 | Sou | Otuki | Comparisons of the effect of anticoagulation therapies on the coagulation system including the tissue factor pathway |
| 10830 | Akihiro | Tobe | Comparison of Anti-Factor Xa Activity Value among Factor-Xa Inhibitors in Japanese Non-Valvular Atrial Fibrillation Patients |
| 10862 | Mitsutoshi | Asano | Clinical Assessment of Graded Dose of Dabigatoran versus Warfarin in Patients with Atrial Fibrillation Requiring Anti-coagulation and Dual Antiplated Therapy |
| 11114 | Tadashi | Wada | The Risk and Safety of Discontinuing Oral Anticoagulation Therapy after Ablation for Atrial Fibrillation in Patients with High CHADS2 Score. |
| 11264 | Eiji | Yamashita | Novel Oral Anticoagulants Reduce the Prevalence of Left Atrial Thrombus Prior to Atrial Fibrillation Ablation |
| 11271 | Hirofumi | Machii | Determination of Left Atrial Strain is Superior Beyond CHADS2 and CHA2DS2-VASc Scoring for Initiating Anticoagulation Treatment in Atrial Fibrillation |
| 11335 | Takuro | Nishimura | A New Device, Dielectric Coagulometer is able to Assess the Previously-undetected Changes in Whole Blood Coagulability under Factor Xa Inhibitor |
| 11336 | Hideo | Amano | The Usefulness of NOACs for Triple Therapy with Dual Antiplatelet Therapy Comparing to Warfarin |
| 11447 | Kunihiro | Nishida | Impaired Renal Function Predicts Increased Risk of Gastrointestinal Bleeding Events in Patients with Atrial Fibrillation |
| 11452 | Takanari | Fujita | Initial result of edoxaban in the real world |
| 11468 | Atsushi | Doi | Incidence and Predictors of Silent Cerebral Lesions after Catheter Ablation for Atrial Fibrillation in Patients Treated with Oral Anticoagulants |
| 11478 | Takeshi | Fujiwara | Gender Difference of Thromboembolic Milieu in Japanese Non-valvular Atrial Fibrillation Patients: Comparison Between Modified CHA2DS2-VASc and Modified CHA2DS2-VA Scoring Systems |
| 11508 | Yutaka | Yonezawa | Estimated Glomerular Filtration Rate (eGFR) and Creatinine Clearance (Cock-croft Gault) Differ in the Japanese Population? |
| 11510 | Junji | Yamaguchi | Perioperative Management of Antithrombotic Therapy: Assessment of Appropriate Strategy for Preventing Events |
| 11523 | Yuki | Matsumoto | The relationship between cardioembolic stroke and vascular endothelial dysfunction in patients with non-valvular atrial fibrillation |
| 11602 | Daisuke | Sueta | A Novel Quantitative Assessment of Whole Blood Thrombogenicity in Patients Treated With a Non-vitamin K Oral Anticoagulant |
| 11606 | Masahiko | Hara | D-dimer measured at presentation is associated with 10-year mortality in patients with deep venous thrombosis |
| 11658 | Satomi | Hamada | Novel Dielectric Blood Coagulometry Can Evaluate Factor Xa and Thrombin Activity Individually |
| 11723 | Keita | Miki | Effectiveness and Safety of NOACs in Atrial Fibrillation Patients Undergoing Ablation Therapy with a Special Reference to Left Atrial Function |
| 11802 | Kentaro | Goto | Prognostic Implications of D-dimer for the Patients with Out-of-hospital Cardiopulmonary Arrest. |
| 11819 | Hiroshi | Koiwaya | Effectiveness of Non-vitamin K-antagonist oral anticoagulant of the acute phase therapy for the patients with symptomatic venous thromboembolism |
| 11900 | Masataka | Ogiso | Triple therapy versus dual antiplatelet therapy in atrial fibrillation patients with high bleeding risk after percutaneous coronary intervention |
| 11975 | Hiroaki | Ichikawa | Rivaroxaban ameliorates renal damages in renin-tragenic hypertensive mice |
| 11990 | Hiromasa | Katoh | Evaluation of Anti-Inflammatory and Anti-Atherosclerotic Effects of factor-Xa inhibitors in Patients with Atrial Fibrillation |
| 12033 | Yae | Matsuo | Procedural learning curve of percutaneous left atrial appendage closure for stroke prevention in six years |
| 12156 | Miki | Horigome | Risk Stratification of Asymptomatic Deep Venous Thrombosis in Preoperative Japanese Patients, a Retrospective Study Based on Diagnosis Using Compression Ultrasonography |
| 12208 | Youichi | Tsutano | The Relationship between antithrombotic therapy and bleeding and thrombotic events in the DES era |
| 12241 | Marina | Arai | The Predictive Factor of Catheter-directed Thrombolysis (CDT) for Patients with Deep Vein Thrombosis (DVT) |
| 12285 | Yugo | Yamashita | Persistence and Discontinuation of Oral Anticoagulants in Patients with Atrial Fibrillation in the Real-World: The Fushimi AF Registry |
| 12366 | Raisuke | Iijima | Modified-HAS-BLED score to predict Major Bleeding in patients with Atrial Fibrillation undergoing Stent implantation |
| 12435 | Yoshimi | Numao | Usefulness of evaluation by time in therapeutic range and international normalized ratio variability in atrial fibrillation patients under warfarin therapy |
| 12436 | Yoshimi | Numao | Predictors of international normalized ratio variability in patients with atrial fibrillation under warfarin therapy |
| 12472 | Shigeki | Miyata | Safety and Efficacy of Argatroban in Patients with Heparin-induced Thrombocytopenia – an Interim Report of a Post-marketing Surveillance Study |
| 12475 | Yusuke | Hattori | Single Drug Approach with Edoxaban is Effective and Safe for the Patients with Venous Thromboembolism |
| 12523 | Shinya | Suzuki | Discrepancy between Direct and Indirect Measurement of Serum Concentration of Rivaroxaban in Atrial Fibrillation (Sub-analysis of CVI ARO Study 1) |
| 12561 | Hiroshi | Inoue | Apixaban Post-Marketing Surveillance for Primary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Insight from STANDARD Study |
| 12582 | Tetsuro | Miyazaki | Higher AA Levels and Lower EPA/AA Ratio in Patients with New Onset of Deep Vein Thrombosis after Total Knee Arthoplasty |
| 12623 | Masafumi | Fukumitsu | Central pulmonary artery occlusion increases characteristic impedance rather than peripheral resistance in normal rats |
| 12648 | Yu | Oimatsu | T-TAS Predicts CYP2C19 Poor Metabolizer and Prognosis in Patients Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy |
| 12675 | Yoko | Yamada | Associations between discontinuation of anticoagulant therapy and frailty among older inpatients |
| 12735 | Kenichi | Hiasa | Predictive value of the change of coagulation markers for device-related thrombosis |
| 12764 | Hiroshi | Shiroto | Impact of Plasma D-dimer Levels and Infarct Size on Functional Outcome in Patients with Cardioembolic Stroke in the Anterior-Circulation Resion |
| 12911 | Yae | Matsuo | Left atrial appendage closure for stroke prevention in octogenarian atrial fibrillation patients |
| 13041 | Shinya | Ichikawa | Bleeding risk stratification using microchip flow-chamber system in patients receiving multiple antithrombotic agents |
| 13067 | Taiki | Kinjo | Heart Failure Severity and INR Variability under Warfarin Therapy in Nonvalvular Atrial Fibrillation Patients |
| 13139 | Naoki | Maniwa | Association of Insufficient of Oral Anticoagulation Therapy with Embolic Events in First Acute Myocardial Infarction Patient with Left Ventricular Dysfunction |
| 13155 | Hirokazu | Kondo | Assessment of rivaroxaban and apixaban concentration and prothrombin time in patients with non-valvular atrial fibrillation |
| 13211 | Daiki | Akiyama | Comparison of Safety between Warfarin and NOAC with Dual Antiplatelet Therapy after Percutaneous Coronary Intervention |
| 13248 | Ryuhei | Saito | Nutri-pharmacogenomic Interaction of Intestinal Cholesterol Transporter (NPC1L1) with VKORC1 as a Determinant of Warfarin Anticoagulation |
| 13323 | Nobutoyo | Masunaga | Clinical Outcomes of Anti-platelet Therapy in Atrial Fibrillation Patients Without Atherosclerotic Disease: The Fushimi AF Registry. |
| 13338 | Monami | Ando | A Rebound Effect of Rivaroxaban may Increase the Risk of Hypercoagulability after the Ablation of Atrial Fibrillation |
| 13350 | Monami | Ando | Increased Coagulability after the Cryoballoon Ablation of Atrial Fibrillation |
| 13384 | Shun | Morishita | Catheter-directed Mechanical Thrombectomy in Treatment of Acute Pulmonary Embolism |
| 13400 | Hiroaki | Tsujita | The association between serum uric acid levels and plasma thrombomodulin levels in patient with acute coronary syndrome. |
| 13442 | Yasuji | Doi | Role of Retrievable Inferior Vena Cava Filter in Venous Thromoembolism |
| 13509 | Ippei | Tsuboi | Feasibility and Safety of Twice Interruption of New Oral Anticoagulants with Unfractionated Heparin Bridging in Patients Undergoing Atrial Fibrillation Ablation |
| 13530 | Masahiro | Suzuki | Efficacy and safety of improper use of low dose Rivaroxaban. |
| 13531 | Hiroki | Niikura | Differential Pattern of Major Bleeding among patients with Triple Anticoagulant Therapy after Stent Implantation. |
| 13550 | Takaki | Matsumoto | Comparison between Edoxaban and Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Incidence in Japanese Patients with Orthopedic Surgery |
| 13612 | Shinya | Suzuki | Predictors of Trough Serum Concentration under Rivaroxaban in Japanese Patients with Atrial Fibrillation (Sub-analysis of CVI ARO 1) |
| 13711 | Akinori | Sairaku | Activated partial thromboplastin time measured after overnight heparin bridging helps heparinization during ablation of atrial fibrillation |
| 13803 | Kazunori | Otsui | The Direct Factor Xa Inhibitors Have a Differential Effect on Endogenous Thrombolysis Compared with Warfarin |
| 13833 | Susumu | Takase | Current Trend and Issues in Periprocedural Anticoagulation Protocol for Catheter Ablation of Atrial Fibrillation. |
| 13837 | Tomoyuki | Kunishima | A Study of Safety and Efficacy of Anticoagulant Therapy in the Treatment of Atrial Fibrillation In Kanagawa(ASSAF-K) -the second announcement- |
| 13894 | Takeya | Minami | The renovated program for the management of asymptomatic deep vein thrombosis in perioperative period. |
| 20036 | Keitaro | Senoo | Comparison of risks and outcomes amongst elderly patients with atrial fibrillation A comparative analysis of Japan and United Kingdom subjects |
| 20037 | Keitaro | Senoo | Is ethnicity associated with stroke amongst elderly AF patients without oral anticoagulation? A comparative analysis of Japan and UK subjects |
| 20067 | Jia-Hui | Zhang | Thienopyridines Induce Intestinal Epithelial Injury by Activating p38 MAPK via Occludin |
